BSX vs PROF · P/E 20, rev $16.75B vs rev $10.7M
Boston Scientific Corp (BSX) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. PROF currently screens at market cap $238.7M.
Not investment advice. Open the BSX and PROF stock pages for the full models.
Not investment advice.